Health
Ozempic’s health benefits keep growing, but are the risks worth it?
One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.
Glucagon-like peptide-1 receptor (GLP-1) agonists — which contain either semaglutide or liraglutide — are prescribed to treat type 2 diabetes and obesity, but previous studies have linked the drugs to other, unexpected benefits.
Researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) St. Louis Health Care System studied the health outcomes of more than two million veterans with diabetes who took Ozempic or another type of GLP-1 drug between Oct. 1, 2017 and Dec. 31, 2023, according to a university press release.
OZEMPIC ‘MICRODOSING’ IS THE NEW WEIGHT-LOSS TREND
They then compared those outcomes to veterans who took non-GLP-1 diabetes medications.
One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show. (iStock)
The study, published in the journal Nature on Jan. 20, identified “widespread associations” between Ozempic and some significant health benefits.
Those benefits included reduced risks of neurocognitive disorders like Alzheimer’s and dementia, seizures, and addiction to harmful substances such as alcohol, cannabis, stimulants and opioids.
Other positive health effects included lower risks of suicidal ideation, self-harm, bulimia and psychotic disorders such as schizophrenia.
OZEMPIC COULD HELP REDUCE ALZHEIMER’S RISK FOR SOME, STUDY SUGGESTS: ‘SHIFTING THE PARADIGM’
“GLP-1s have many benefits for at least 42 conditions beyond weight loss – from addiction disorders to memory/cognition problems, blood clots, and infections,” lead study author Ziyad Al-Aly, clinical epidemiologist at Washington University in St. Louis, told Fox News Digital.
Ozempic and other GLP-1 drugs act on receptors in the brain that are involved in impulse control, reward and addiction, Al-Aly noted, which could explain why they are effective in reducing cravings for food and addictive substances.
“GLP-1s have many benefits for at least 42 conditions beyond weight loss.”
“These drugs also reduce inflammation in the brain and result in weight loss; both of these factors may improve brain health and explain the reduced risk of conditions like Alzheimer’s disease and dementia,” he added.
They also found, however, that GLP-1 drugs were linked to several adverse side effects.
Novo Nordisk is the maker of Ozempic, which is approved for type 2 diabetes treatment and reduced risk of cardiovascular events. (Getty Images)
The risk of gastrointestinal problems — including nausea, vomiting, diarrhea and a rarer paralysis of the stomach — were widely known before this new study, the researcher noted.
The new finding, however, was that these drugs can negatively affect the pancreas and kidneys. They were also linked to a higher chance of developing arthritis.
DIABETES AND WEIGHT LOSS DRUGS SHOWN TO REDUCE ALCOHOL-RELATED HOSPITALIZATIONS, STUDY FINDS
“While these adverse effects are uncommon, they can be very serious; physicians must be vigilant for signs of pancreatitis (inflammation of the pancreas) and monitor kidney function among people taking GLP-1RA medications,” Al-Aly stated in the press release.
“Kidney problems can occur without symptoms until the condition is at an advanced stage with limited treatment options.”
Decreased obesity has long been linked with less inflammation in every body system, an expert pointed out. (iStock)
The study, which was funded by the U.S. Department of Veterans Affairs, did have some limitations, the researchers acknowledged.
“This is a discovery approach involving more than two million people and is not a randomized trial,” Al-Aly told Fox News Digital.
“People with real weight loss are happier overall — they feel empowered.”
Seth Kipnis, MD, medical director of bariatric and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center, was not involved in the study but said it confirms what he has seen in his own clinical practice.
“People with real weight loss are happier overall — they feel empowered that they can finally control their weight,” he said in a statement sent to Fox News Digital.
The risk of gastrointestinal problems — including nausea, vomiting, diarrhea and a rarer paralysis of the stomach — were widely known before this new study. (iStock)
Decreased obesity has long been linked with less inflammation in every body system, Kipnis pointed out.
“GI problems and renal problems will always be seen if people are not eating correctly and maintaining hydration,” he said. “If you take these medications without nutritional education, they can be harmful.”
Recommendations and predictions
Based on the findings, the researchers noted, people should be aware that these drugs have not only a “broad beneficial profile,” but also important risks.
“People should use the information to discuss with their provider whether GLP-1 is the right medication for them,” Al-Aly recommended.
“A person with a lot of GI issues may find these meds intolerable.”
“A person who is trying to lose weight and quit smoking or drinking may find GLP-1s especially useful – helping hit two birds with one stone — but a person with a lot of GI (gastrointestinal) issues may find these meds intolerable,” he went on.
“Each person’s health profile is different. Pros and cons should be discussed with the provider.”
CHEAP OZEMPIC KNOCK-OFFS HAVE RISEN IN POPULARITY
Given their effectiveness at causing weight loss and improving health, GLP-1 drugs will likely become more common and increase in use, Hackensack’s Kipnis predicted.
“We have been prescribing many long-term drugs for hypertension, heart disease, high cholesterol, diabetes, arthritis, reflux and many other diseases without hesitation,” he said.
The new study revealed that GLP-1 drugs could negatively affect the pancreas and kidneys. (iStock)
“This new class of drug, as it lowers obesity, has the potential to lower the use of every other drug that is used to treat obesity-related conditions.”
Not every doctor should prescribe these medications, however, according to Kipnis.
“Doctors with weight management programs and nutrition education programs would likely have better outcomes and fewer side effects,” the doctor said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Novo Nordisk, the maker of Ozempic (approved for type 2 diabetes treatment and reduced risk of cardiovascular events) and Wegovy (approved for weight management and reduced risk of cardiovascular events), provided the following statement to Fox News Digital.
“Semaglutide has helped millions of people fight chronic diseases such as type 2 diabetes, cardiovascular disease and obesity. As we look to help even more people with chronic diseases, we are exploring the potential of semaglutide in several other disease states.”
Wegovy, also made by Novo Nordisk, is FDA-approved for weight management and reduced risk of cardiovascular events. (Steve Christo – Corbis/Corbis via Getty Images)
“Patient safety is of utmost importance to Novo Nordisk. The known risks and benefits of semaglutide medicines are described in their FDA-approved product labeling and we work closely with authorities and regulatory bodies worldwide to continuously monitor the safety profile of our products.”
For more Health articles, visit www.foxnews.com/health
The company added that the “totality of data” from previous studies “provides reassurance of the safety profile of semaglutide.”
NEWYou can now listen to Fox News articles!
A widely prescribed opioid painkiller showed limited effectiveness and increased risk of negative effects in a new analysis published in BMJ Evidence-Based Medicine.
The study examined tramadol, a common prescription opioid used to treat chronic pain.
Tramadol has historically been perceived as a safer or less addictive opioid, which has contributed to its widespread use in chronic pain treatment, the study authors noted.
PSYCHIATRIST REVEALS HOW SIMPLE MINDSET SHIFTS CAN SIGNIFICANTLY REDUCE CHRONIC PAIN
“Often, we may use tramadol to avoid more addictive drugs like other opioids, though in fact tramadol is a synthetic opioid. It is much milder,” Dr. Marc Siegel, senior medical analyst for Fox News, told Fox News Digital.
In the new analysis, researchers used data from 19 randomized clinical trials involving 6,506 adults with conditions including osteoarthritis, chronic low back pain, neuropathic pain and fibromyalgia. All the studies compared tramadol to a placebo treatment.
The level of pain relief associated with tramadol fell below the threshold typically considered clinically important. (iStock)
Overall, tramadol led to a small decrease in pain, but the amount of relief was less than what is usually considered clinically meaningful, the authors reported.
“It is notable how minimal the pain reduction was and how clearly the study highlighted the elevated risk of serious adverse events, even over relatively short trial durations,” Alopi M. Patel, M.D., pain medicine physician at Icahn School of Medicine at Mt. Sinai in New York City, told Fox News Digital. (Patel was not involved in the study.)
MORE PEOPLE TURN TO ACUPUNCTURE FOR BACK PAIN AS STUDY SHOWS RELIEF
Participants receiving tramadol experienced a higher risk of adverse events, both serious and non-serious, compared with those receiving a placebo.
Serious adverse events primarily included cardiovascular events, such as chest pain, coronary artery disease and congestive heart failure. The authors concluded that tramadol likely increases the risk of heart-related issues.
Serious adverse events were primarily driven by cardiovascular outcomes, including chest pain, coronary artery disease and congestive heart failure. (iStock)
The authors concluded that the benefits of tramadol for chronic pain are small and that the harms likely outweigh the benefits. The findings call into question the use of tramadol for chronic pain conditions, they stated.
Study limitations
Most of the trials included in the analysis were short, with treatment periods ranging from two to 16 weeks and follow-up periods from three to 15 weeks.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
This limited the ability to assess long-term outcomes, the researchers acknowledged.
The authors reported that many outcomes had a high risk of bias, which may have exaggerated the apparent benefits and minimized the reported harms.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The trials involved several different types of chronic pain, but the data were not detailed enough to draw conclusions for any specific condition. This makes it “harder to generalize the findings to specific patient populations,” noted Patel.
Most trials were short in duration and compared tramadol only with a placebo — limiting conclusions about long-term effects and comparisons with other treatments. (iStock)
Though the study has value, Siegel said, “looking at slight increased rates of cancer or heart disease among those on the drug is completely misleading, because it is not controlled for other factors and there is no evidence or hint of causation.”
“You would have to first look at underlying characteristics of that group who took the meds.”
CLICK HERE FOR MORE HEALTH STORIES
The doctor also pointed out that the study “doesn’t compare [tramadol] with full-on opioids like Percocet.”
Experts emphasize that patients should not stop taking tramadol abruptly, as doing so can lead to withdrawal symptoms. Those looking to change their medication should consult a doctor.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“I recommend that clinicians and patients engage in transparent, shared decision-making that considers tramadol’s modest benefits alongside its risks,” Patel advised.
Fox News Digital reached out to several manufacturers of tramadol requesting comment.
New flu strain emerging as a severe health threat
Fox News senior medical analyst Dr. Marc Siegel joins ‘America’s Newsroom’ to warn of a new strain of the flu that is spiking hospitalizations across the country and newfound risks of medical marijuana’s link to psychosis.
NEWYou can now listen to Fox News articles!
A new form of the flu, which is highly contagious and aggressive, is sweeping the nation this season.
A mutation of influenza A H3N2, called subclade K, has been detected as the culprit in rising global cases, including in the U.S.
The World Health Organization stated on its website that the K variant marks “a notable evolution in influenza A (H3N2) viruses,” which some say calls into question the effectiveness of this season’s influenza vaccine against the strain.
‘AGGRESSIVE’ NEW FLU VARIANT SWEEPS GLOBE AS DOCTORS WARN OF SEVERE SYMPTOMS
The K variant causes more intense flu symptoms, including fever, chills, headache, fatigue, cough, sore throat and runny nose, according to experts.
Multiple states in the northeast are reporting high rates of respiratory illness this month. (iStock)
Among 216 influenza A(H3N2) viruses collected since Sept. 28, 89.8% belonged to subclade K, a CDC report states.
The agency continues to release a weekly influenza surveillance report, tracking which states are seeing the most activity for outpatient respiratory illness.
5 THINGS YOU NEED TO KNOW BEFORE GETTING YOUR FLU SHOT, ACCORDING TO DOCTORS
Below are the states and regions within the highest range of reported medical visits, not necessarily confirmed influenza cases, as of the week ending Dec. 13.
The CDC’s weekly influenza surveillance report, an outpatient respiratory illness activity map, based on data reported to ILINet for the week ending Dec. 13, 2025. (CDC FluView)
Very High (Level 1)
Very High (Level 2)
Very High (Level 3)
- New Jersey
- Rhode Island
- Louisiana
- Colorado
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
High (Level 1)
- Massachusetts
- Connecticut
- Michigan
- Idaho
- South Carolina
High (Level 2)
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
High (Level 3)
- Washington, D.C.
- Maryland
- North Carolina
- Georgia
The CDC has estimated that there have been at least 4.6 million illnesses, 49,000 hospitalizations and 1,900 flu deaths this season so far. The flu vaccine is recommended as the best line of defense against the virus.
The flu vaccine is recommended as the best line of defense against the virus. (iStock)
In an interview with Fox News Digital, Dr. Neil Maniar, professor of public health practice at Boston’s Northeastern University, shared details on the early severity of this emerging flu strain.
“It’s becoming evident that this is a pretty severe variant of the flu,” he said. “Certainly, in other parts of the world where this variant has been prevalent, it’s caused some severe illness, and we’re seeing an aggressive flu season already.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Subclade K is the “perfect storm” for an aggressive flu season, Maniar suggested, as vaccination rates overall are down, and it’s uncertain whether this year’s flu vaccine directly addresses this specific mutation.
“The vaccine is very important to get, but because it’s not perfectly aligned with this variant, I think that’s also contributing to some degree to the severity of cases we’re seeing,” he said. “We’re going in [to this flu season] with lower vaccination rates and a variant that in itself seems to be more aggressive.”
Subclade K has “caused some severe illness, and we’re seeing an aggressive flu season already,” a doctor said. (iStock)
Maniar stressed that it’s not too late to get the flu vaccine, as peak flu season has not yet arrived.
“The vaccine still provides protection against serious illness resulting from the subclade K variant that seems to be going around,” he said. “There are likely to be lots of indoor gatherings and other events that create risk of exposure, so protection is important.”
CLICK HERE FOR MORE HEALTH STORIES
Even healthy individuals can become seriously ill from the flu, Maniar noted, “so a vaccine is beneficial for almost everyone.”
“Individuals typically start to develop some degree of protection within a few days and gain the full benefit within about two weeks, so now is the time for anyone who hasn’t gotten the vaccine yet.”
NEWYou can now listen to Fox News articles!
Former U.S. Sen. Ben Sasse of Nebraska announced this week that he has been diagnosed with metastatic stage 4 pancreatic cancer, calling the disease “a death sentence” in a message posted on X.
Sasse, 53, said the cancer has spread and acknowledged that he has “less time than I’d prefer,” although he also mentioned recent scientific advances and his intention to pursue treatment.
“I’m not going down without a fight,” Sasse said when revealing his diagnosis. “One sub-part of God’s grace is found in the jaw-dropping advances science has made the past few years in immunotherapy and more.”
HIDDEN FACTOR IN CANCER TREATMENT TIMING MAY AFFECT SURVIVAL, RESEARCHERS SAY
Pancreatic cancer is known to be one of the deadliest forms of cancer, with ongoing research efforts aiming to improve outcomes.
Below are six key things to know about the disease.
No. 1: Pancreatic cancer is often diagnosed late and is highly deadly
Pancreatic cancer is notoriously aggressive and difficult to treat, according to the American Cancer Society. Most patients are not diagnosed until the disease has already spread to other organs, largely because there aren’t reliable screening tests and early symptoms can be vague or absent.
Ben Sasse, a former U.S. senator from Nebraska, announced that he has been diagnosed with metastatic stage 4 pancreatic cancer. (Getty Images; iStock)
The ACS estimates that 67,440 Americans will be diagnosed with pancreatic cancer in 2025, and about 51,980 are expected to die from it. The tumor’s biology creates physical and chemical barriers that reduce the effectiveness of many traditional treatments.
No. 2: New immunotherapies are showing early promise
Researchers at UCLA recently reported progress on an experimental, off-the-shelf, cell-based immunotherapy designed to attack pancreatic cancer.
FORMER GOP SEN. BEN SASSE REVEALS STAGE-4 CANCER DIAGNOSIS: ‘IT’S A DEATH SENTENCE’
In mouse studies, the therapy slowed tumor growth, extended survival and remained effective even after the cancer had spread to other organs, such as the liver and lungs.
The treatment uses special immune cells called natural killer T (NKT) cells, which are genetically modified so they can specifically recognize and attack pancreatic cancer cells.
Early research is exploring new approaches to pancreatic cancer, including experimental immunotherapies and studies of risk factors, but many findings are still in preclinical or observational stages. (iStock)
Unlike personalized therapies, the NKT cells are naturally compatible with different immune systems and can be mass-produced from donor stem cells.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Researchers estimate that one donor could supply cells for thousands of treatments, with a potential cost of around $5,000 per dose. All testing so far has been done in mice, and human trials have not yet begun.
No. 3: Diet and gut health may affect treatment recovery
Separate research from the Massachusetts Institute of Technology has suggested that the amino acid cysteine could help the gut heal after cancer treatments, such as chemotherapy and radiation.
In mouse studies, cysteine — found in foods like meat, eggs, dairy products, legumes and nuts — helped to regenerate intestinal stem cells that are often damaged during cancer therapy.
Researchers are studying how diet, including nutrients such as cysteine found in high-protein foods, may help support recovery from pancreatic cancer treatments. (iStock)
Additional unpublished research showed benefits after treatment with 5-fluorouracil, a chemotherapy drug used for colon and pancreatic cancers.
Researchers emphasized that human studies are still needed and that cysteine is not a cure for cancer itself.
No. 4: Alcohol and lifestyle factors may raise cancer risk
Recent research published in PLOS Medicine by the International Agency for Research on Cancer found that alcohol consumption is associated with an increased risk of pancreatic cancer.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study followed 2.5 million people for about 16 years, finding that each additional 10 grams of ethanol consumed per day was linked to a 3% increase in risk. Higher intake levels were associated with greater risk, particularly with beer and spirits.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Researchers noted that the study was observational and that more work is needed to understand lifetime drinking patterns.
No. 5: Symptoms are often subtle and easily missed
When symptoms do occur, they can include abdominal pain that spreads to the sides or back, loss of appetite and unexplained weight loss, according to Mayo Clinic.
Some patients develop jaundice — yellowing of the skin and whites of the eyes — along with light-colored or floating stools, dark urine and itching.
Common warning signs of pancreatic cancer can include abdominal pain, unexplained weight loss and loss of appetite. (iStock)
Other possible signs include a new diagnosis of diabetes (or diabetes that becomes harder to control), pain and swelling in an arm or leg that may be linked to a blood clot, and persistent tiredness or weakness.
Those who are experiencing symptoms should consult with a healthcare professional.
No. 6: Age, genetics and health conditions can raise risk
Pancreatic cancer risk is influenced by a combination of genetic, medical and lifestyle factors.
The disease becomes more likely with age, and men are slightly more susceptible, according to the ACS. Those with a family history or inherited genetic mutation also have a higher risk, as do people with type 2 diabetes, obesity and lack of physical activity.
CLICK HERE FOR MORE HEALTH STORIES
Diets high in processed or red meats and low in fruits and vegetables, as well as high alcohol consumption, may also contribute to pancreatic cancer risk, along with some occupational chemical exposures, per multiple cancer agencies.
Experts note, however, that many people are diagnosed with the disease despite having no clear risk factors.
Deirdre Bardolf, Ashley J. DiMella, Alex Nitzberg and Angelica Stabile, all of Fox News Digital, contributed reporting.
Car Radio, Season 6, Podcast 267: 2025 Detroit News Vehicle of the Year
Mission District miracle: S.F. nonprofit buys building, and its tenants breathe a little easier
Jadeveon Clowney’s veteran presence, effort turns heads as Cowboys look to 2026 roster
Miami Fire Rescue warns of e-bike battery fire risks as popularity grows
‘Christmas angel’ donates $25,000 for Boston’s St. Francis House annual meal for hundreds of guests
Florida High School Football Rankings: Top 25 teams – Oct. 21
Cleary's 21 help Le Moyne down Central Connecticut State 69-64 in OT
How old is Bo Nix? What to know about Oregon quarterback ahead of 2024 NFL Draft
99th annual Pony Swim held in Virginia
Video: ‘It Didn’t Have to Happen This Way:’ U.Va. Faculty Call for Review of Police Response to Protests
Trump lists accomplishments, says ‘Radical Left Scum’ are ‘failing badly’ in Christmas message
Ukraine accepts demilitarised zone to end Russia war, but do DMZs work?
Into the void: how Trump killed international law
Nearly 20 states sue HHS over declaration to restrict gender transition treatment for minors
Europe defends its digital rules after US targets Breton with visa ban
-
Maine1 week agoElementary-aged student killed in school bus crash in southern Maine
-
New Mexico1 week agoFamily clarifies why they believe missing New Mexico man is dead
-
Massachusetts1 week agoMIT professor Nuno F.G. Loureiro, a 47-year-old physicist and fusion scientist, shot and killed in his home in Brookline, Mass. | Fortune
-
Health1 week ago‘Aggressive’ new flu variant sweeps globe as doctors warn of severe symptoms
-
Culture1 week agoTry This Quiz and See How Much You Know About Jane Austen
-
Education1 week agoVideo: How We Tested Earplugs for Sleeping
-
World6 days agoPutin says Russia won’t launch new attacks on other countries ‘if you treat us with respect’
-
Maine1 week agoFamily in Maine host food pantry for deer | Hand Off